2 new drugs approved by the FDA: Teflaro (ceftaroline) and Latuda (lurasidone)

The FDA recently approved 2 new drugs:

• Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA). Teflaro is marketed by New York City-based Forest Laboratories.
• Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia. Latuda is manufactured by Sunovion Pharmaceuticals Inc. of Fort Lee, N.J.

Read about these drugs here on the FDA website.